AstraZeneca vaccine candidate questioned after puzzling trial results AstraZeneca faces increased scrutiny after reporting a 90% efficacy rate for a one-and-a-half dose vaccine regimen that the company admitted was given ... Read more

Rebif/remdesivir combo no longer being tested in severely ill COVID-19 patients The National Institute of Allergy and Infectious Diseases has stopped enrolling severely ill COVID-19 patients into a Phase 3 ... Read more

Promising early results published for Russia vaccine Russia’s approved COVID-19 vaccine, called Sputnik V, appears to be safe and trigger immune reactions in adults, according to results recently published in ... Read more